ASTCT @ASTCT

🧬 As transplantation and cellular therapies continue to evolve, so do the toxicities clinicians must recognize, prevent, and manage. Join ASTCT for the 5th International Conference on Toxicities of Transplantation and Cellular Therapies, November 13–14 in Chicago. Explore the mechanisms and symptom burden of toxicities and the latest approaches to prevention, early recognition, and treatment. Register: ow.ly/PvPN50ZNr2Y

Join ASTCT on Sept. 30 for Consensus Grading for Toxicities After Immune Effector Cell Therapy, a webinar exploring updated consensus criteria designed to support more consistent toxicity assessment across clinical trials and real-world practice. The session will build on the original framework for CRS and ICANS and address emerging toxicities, including IEC-HS, hematotoxicity, non-ICANS neurologic complications, enterocolitis, and more. 📅 September 30 | 2–3 p.m. CT ow.ly/J8Tj50ZNqPn

📣 Call for faculty! The Fundamentals of HCT Training Course is seeking speakers to share their expertise and help build the next generation of knowledge in hematopoietic cell transplantation. If you have clinical or scientific expertise and a passion for education, we’d love to hear from you. 🔗 Learn more and submit your interest: ow.ly/p11150ZNqqi

Registration is open for ASTCT’s Clinical Education Conference, taking place virtually October 22–23. Build practical knowledge in hematopoietic cell transplantation and cellular therapy through case-based education, focused sessions, and opportunities to learn from experienced clinicians. CEC includes dedicated tracks for adult and pediatric care, as well as professionals who are newer to the field. 📅 October 22–23, 2026 💻 ow.ly/H2Vg50ZNqvl

Today we recognize World Marrow Donor Day and the donors who make lifesaving hematopoietic cell transplantation possible. For patients who need a transplant, finding a compatible donor can be a critical step in their treatment journey. Every donor who joins a registry represents another possibility for a patient searching for a match. Today and every day, we’re grateful for the individuals who step forward to give others a chance at life.

🧬 The future of gene therapy is taking shape, and the conversation is happening in Boston. Join ASTCT for the 2026 Gene Therapy Summit, November 4–5 at Harvard Medical School. This interactive meeting brings together clinicians, researchers, academic centers, biotechnology leaders, and multidisciplinary experts to explore the rapidly evolving field of ex vivo gene therapy using hematopoietic stem cells. 🔗 Learn more and register ow.ly/VVKL50ZNq4K

New on ASTCT's Nucleus: A comprehensive review from the ASTCT–NMDP ACCESS Initiative highlights persistent disparities in access to hematopoietic cell transplantation and CAR- T therapy, showing how factors such as race, age, income, and insurance coverage can impact care. Learn what current data reveal—and where improvements are needed to advance health equity. Read more: ow.ly/Rxc850ZNqce

📖 Meet the Incoming Editor of Transplantation and Cellular Therapy David L. Porter, MD, shares his vision for ASTCT’s official journal, the future of scientific publishing, and the advances in transplantation, cellular therapy, and gene therapy that are shaping patient care. Learn how the journal will continue to support researchers, clinicians, and trainees across the field. 🔗 Read the Q&A: ow.ly/OWqQ50ZNpqX

⏰ Tomorrow is the deadline! ASTCT Premier Award nominations close tomorrow, September 18. This is your last chance to recognize a colleague whose leadership, scientific contributions, clinical excellence, or service has made a meaningful difference to the HCT and cellular therapy community. 🏆 E. Donnall Thomas Lecture 🏆 Lifetime Achievement Award 🏆 Public Service Award Nominate someone deserving today: ow.ly/gPNP50ZNpmE

What does the latest evidence say about B-cell depletion for cGVHD prevention and about fludarabine versus bendamustine for lymphodepletion before CAR T? Join ASTCT’s Pharmacy SIG Journal Club on September 23 for two focused, evidence-based presentations followed by discussion and Q&A. 📅 September 23 | 2–3 p.m. CT / 3–4 p.m. ET 💻 Virtual- ow.ly/nuWg50ZNp2N 💊 1.0 contact hour of continuing pharmacy education is available.

The latest ASTCT Consensus Grading for Toxicities after Immune Effector Cell Therapy has been published in Transplantation and Cellular Therapy, providing a standardized framework for grading toxicities associated with immune effector cell therapies. ,The guidance maintains and clarifies grading for CRS and ICANS, introduces modified ICE (M-ICE) for children and patients with developmental delays, and addresses emerging toxicities including hematotoxicity, IEC-HS and non-ICANS neurotoxicities. 📖 Read the full guideline: ow.ly/59na50ZOqrR @ASTCT_Journal

Join William Robinson, MD, PhD, as he explores how these therapies could reshape the treatment of autoimmune disease—and what the field needs to consider as research continues to advance. Bispecific antibodies and CAR T-cell therapies are emerging as transformative approaches for autoimmune disease. This session will examine the progress made to date, the evolving therapeutic landscape, and the opportunities ahead. Link: ow.ly/CkPx50ZNnVT

Join colleagues virtually October 22–23 for practical, case-based education focused on the diagnosis and treatment of complications in hematopoietic cell transplantation and cellular therapies. CEC features dedicated learning opportunities for adult and pediatric care, along with a track designed specifically for professionals newer to the field. Designed for APPs, fellows, nurses, and in-training professionals. 📅 October 22–23, 2026 Learn More: ow.ly/v3iv50ZNo1Y

Choosing a conditioning approach means weighing more than intensity alone. How do available RTC approaches compare? What trade-offs should factor into regimen selection? And how can patient- and disease-specific characteristics help guide your decision? Analyze the evidence and strengthen your approach to individualized regimen selection, earning free CE credit along the way: ow.ly/1WQp50ZNnSS

Registration for the 2027 Tandem Meetings is open! Join ASTCT and CIBMTR in Orlando, February 17–20, 2027, for four days of cutting-edge science, clinical education, collaboration, and connection across hematopoietic cell transplantation, cellular therapy, and gene therapy. From plenaries and oral abstracts to educational sessions, posters, and opportunities to connect with colleagues, #Tandem27 is where the field comes together. 📍 Orlando, FL 📅 February 17–20, 2027 Register now: ow.ly/BiI350ZO2w0

The September issue of 'Transplantation and Cellular Therapy,' is now available online: astctjournal.org/current @ELShematology

Do you have expertise to share with the next generation of HCT professionals? ASTCT is seeking speakers for the Fundamentals of HCT Training Course. This course helps build foundational knowledge across hematopoietic cell transplantation and cellular therapy—and we’re looking for experts who can bring their experience and perspective to the classroom. If you’re passionate about education and developing the future HCT workforce, consider joining the faculty. 🔗 Learn more and submit your interest: ow.ly/eojG50ZNnI4

There’s still time to recognize a leader who has made a lasting impact on hematopoietic cell transplantation and cellular therapy. ASTCT Premier Award nominations are open for the: • E. Donnall Thomas Lecture • Lifetime Achievement Award • Public Service Award Nominate a colleague whose leadership, expertise, service, or scientific contributions have advanced our field. 📅 Nominations close Friday, September 18. surveymonkey.com/r/VK79VD8

How should clinicians approach transplantation for older patients with TP53-mutated disease? Join ASTCT’s Aging SIG on October 15 for a case-based discussion examining the complex decisions surrounding transplant, including when transplant may not be the best approach. 📅 October 15 | 11 AM CT Register: ASTCT Learning Center: ow.ly/bwW250ZNoPT

The 2027 Tandem Meetings are where the latest advances in hematopoietic cell transplantation, cellular therapy and gene therapy are on display. Have research, data, or clinical insights to share? Submit your abstract for consideration in the 2027 Tandem Meetings scientific program. 📅 Abstract submissions close October 9, 2026. 🔗 ow.ly/8sLr50ZNlNO